Overview

Tuberculosis Prevention for HIV Infected Adults

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study compares three different tuberculosis (TB) prevention regimens against the standard regimen of 6 months of isoniazid. It is being conducted in Soweto, South Africa. People who are HIV positive and have a positive tuberculin skin test without signs of active tuberculosis may join.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Isoniazid
Rifampin
Rifapentine